Glenmark Pharmaceuticals scrip is currently trading at Rs. 400.00, up by 12.40 points or 3.20% from its previous closing of Rs. 387.60 on the BSE.
The scrip opened at Rs. 385.00 and has touched a high and low of Rs. 402.50 and Rs. 381.50 respectively. So far 1, 74,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 406.40 on 11-Jul-2012 and a 52 week low of Rs. 265.00 on 21-Dec-2011.
Last one week high and low of the scrip stood at Rs. 402.50 and Rs. 374.85 respectively. The current market cap of the company is Rs. 10,824 crore.
The promoters holding in the company stood at 48.26% while Institutions and Non-Institutions held 38.90% and 12.84% respectively.
Other top gainers were Strides Arcolab up 2.01%, Ranbaxy Laboratories up 1.81%, Piramal Health care up 1.58%, and DR Reddy's Laboratories up 1.43%.